A carregar...
60 mg·m(−2)·d(−1)柔红霉素联合标准剂量阿糖胞苷诱导治疗≤65岁初治急性髓系白血病患者的疗效和安全性分析
OBJECTIVE: To evaluate the long-term safety and efficacy of high-dose daunorubicin (DNR) (60 mg·m(−2)·d(−1)) combined with standard dose of cytarabine (DA) as induction therapy in patients under 65 years old with newly diagnosed acute myeloid leukemia (AML). METHODS: The complete remission (CR) rate...
Na minha lista:
| Publicado no: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial office of Chinese Journal of Hematology
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364868/ https://ncbi.nlm.nih.gov/pubmed/27801323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.10.015 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|